Two Diseases—One Preclinical Treatment Targeting Glycogen Synthesis

Matthew S. Gentry; Kia H. Markussen; Katherine J. Donohue

doi:10.1007/s13311-022-01240-9

Two Diseases—One Preclinical Treatment Targeting Glycogen Synthesis

Matthew S. Gentry
, Kia H. Markussen
, Katherine J. Donohue

Research output: Contribution to journal › Comment/debate

4 Scopus citations

Original language	English
Pages (from-to)	977-981
Number of pages	5
Journal	Neurotherapeutics
Volume	19
Issue number	3
DOIs	https://doi.org/10.1007/s13311-022-01240-9
State	Published - Apr 2022

Bibliographical note

Funding Information:
This work was supported by National Institute of Health grants R35 NS116824 and P01 NS097197 to M.S.G.

Funding

This work was supported by National Institute of Health grants R35 NS116824 and P01 NS097197 to M.S.G.

Funders	Funder number
National Institutes of Health (NIH)	R35 NS116824
Institute of Neurological Disorders and Stroke National Advisory Neurological Disorders and Stroke Council	P01NS097197

Keywords

AAV9
Adult polyglucosan body disease
Glycogen
Glycogen storage disease
Lafora disease
Neurodegeneration

ASJC Scopus subject areas

Pharmacology
Clinical Neurology
Pharmacology (medical)

Access to Document

10.1007/s13311-022-01240-9

Cite this

@article{e60596a9915e4376ba9d26050bdfc8e3,

title = "Two Diseases{\textemdash}One Preclinical Treatment Targeting Glycogen Synthesis",

keywords = "AAV9, Adult polyglucosan body disease, Glycogen, Glycogen storage disease, Lafora disease, Neurodegeneration",

author = "Gentry, \{Matthew S.\} and Markussen, \{Kia H.\} and Donohue, \{Katherine J.\}",

note = "Funding Information: This work was supported by National Institute of Health grants R35 NS116824 and P01 NS097197 to M.S.G. ",

year = "2022",

month = apr,

doi = "10.1007/s13311-022-01240-9",

language = "English",

volume = "19",

pages = "977--981",

number = "3",

}

TY - JOUR

T1 - Two Diseases—One Preclinical Treatment Targeting Glycogen Synthesis

AU - Gentry, Matthew S.

AU - Markussen, Kia H.

AU - Donohue, Katherine J.

N1 - Funding Information: This work was supported by National Institute of Health grants R35 NS116824 and P01 NS097197 to M.S.G.

PY - 2022/4

Y1 - 2022/4

KW - AAV9

KW - Adult polyglucosan body disease

KW - Glycogen

KW - Glycogen storage disease

KW - Lafora disease

KW - Neurodegeneration

UR - https://www.scopus.com/pages/publications/85128718787

UR - https://www.scopus.com/pages/publications/85128718787#tab=citedBy

U2 - 10.1007/s13311-022-01240-9

DO - 10.1007/s13311-022-01240-9

M3 - Comment/debate

C2 - 35460010

AN - SCOPUS:85128718787

SN - 1933-7213

VL - 19

SP - 977

EP - 981

JO - Neurotherapeutics

JF - Neurotherapeutics

IS - 3

ER -

Two Diseases—One Preclinical Treatment Targeting Glycogen Synthesis

Bibliographical note

Funding

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this